Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-14T20:50:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T21:35:36.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link. The previous study record content appears to be removed or hidden.
    Difference
    18%
    Check dated 2026-09-23T21:42:15.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new page revision v3.7.0 is added and the previous revision v3.6.6 is removed, signaling an update to the page version.
    Difference
    0.1%
    Check dated 2026-09-16T21:36:50.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision label was updated from v3.6.5 to v3.6.6, representing a maintenance update to the page's version identifier. It does not alter the study content or user-visible features.
    Difference
    0.1%
    Check dated 2026-09-02T19:49:07.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision tag on the page has been updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov page. This reflects a minor backend update to the page rather than any change to the study details or enrollment information.
    Difference
    0.1%
    Check dated 2026-08-12T18:22:13.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.